We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

128 hedge funds and large institutions have $1.07B invested in Dr. Reddy's Laboratories in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $1B → $1.07B (+$61M)

0.79% more ownership

Funds ownership: 75.46% → 76.25% (+0.79%)

9% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 46

4% less funds holding

Funds holding: 134 → 128 (-6)

12% less call options, than puts

Call options by funds: $548K | Put options by funds: $623K

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
128
Holders Change
-6
Holders Change %
-4.48%
% of All Funds
3.19%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
42
Reduced
46
Closed
19
Calls
$548K
Puts
$623K
Net Calls
-$75K
Net Calls Change
+$884K

Top Buyers

1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$36.3M
2
Renaissance Technologies
Renaissance Technologies
New York
+$7.09M
3
First Trust Advisors
First Trust Advisors
Illinois
+$6.86M
4
CBOA
Commonwealth Bank of Australia
Australia
+$6.86M
5
Deutsche Bank
Deutsche Bank
Germany
+$4.51M

Top Sellers

1
AQR Capital Management
AQR Capital Management
Connecticut
-$20M
2
AI
Axiom Investors
Connecticut
-$11.1M
3
CS
Credit Suisse
Switzerland
-$7M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$3.12M
5
BlackRock
BlackRock
New York
-$2.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
AAP
126
Arax Advisory Partners
Colorado
$3K -$2.93K -360 -51%
LIA
127
LS Investment Advisors
Michigan
$2K – – –
AI
128
Axiom Investors
Connecticut
– -$11.1M -1,379,500 Closed
HGI
129
Hansberger Growth Investors
Wisconsin
– -$2.78M -346,610 Closed
NMC
130
Nine Masts Capital
Hong Kong
– -$2M -245,595 Closed
Jane Street
131
Jane Street
New York
– -$1.54M -192,395 Closed
TWI
132
Thomas White International
Illinois
– -$1.31M -163,620 Closed
ACI
133
AMP Capital Investors
Australia
– -$1.04M -127,910 Closed
Fidelity International
134
Fidelity International
Bermuda
– -$746K -92,935 Closed
Natixis Advisors
135
Natixis Advisors
Massachusetts
– -$736K -91,635 Closed
ARTA
136
A.R.T. Advisors
New York
– -$693K -86,350 Closed
UBS AM
137
UBS AM
Illinois
– -$506K -63,000 Closed
SSA
138
Schonfeld Strategic Advisors
New York
– -$341K -42,425 Closed
OMCS
139
Old Mutual Customised Solutions
South Africa
– -$313K -39,000 Closed
Invesco
140
Invesco
Georgia
– -$272K -33,830 Closed
HI
141
HBK Investments
Texas
– -$241K -30,000 Closed
FRM
142
Fox Run Management
Connecticut
– -$221K -27,500 Closed
HC
143
Henshaw Capital
Massachusetts
– -$202K -25,160 Closed
AA
144
Apriem Advisors
California
– -$24K -3,000 Closed
FANJ
145
Financial Architects (New Jersey)
New Jersey
– -$4K -500 Closed
Fifth Third Bancorp
146
Fifth Third Bancorp
Ohio
– -$2K -310 Closed
WAM
147
Wealthspire Advisors (Maryland)
Maryland
– +$41 +5 +20%
2 3 4 5
6

RDY Hedge Fund Activity: Q2 2017 in Review

128 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2017, worth a combined $1.07B — up 6.1% from $1B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of RDY and 13 opened new positions — a net loss of 6 holders — while 46 trimmed existing stakes and 42 added.

The largest buyer was Royal Bank of Canada, adding an estimated $36.3M. The largest seller was AQR Capital Management, cutting an estimated $20M.

  • 128 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2017, down from 134 in Q1 2017.
  • Funds reported $1.07B of Dr. Reddy's Laboratories stock for Q2 2017, up 6.1% quarter-over-quarter.
  • 13 funds opened new Dr. Reddy's Laboratories positions in Q2 2017 and 19 closed out, a net change of -6 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q2 2017 was Royal Bank of Canada, an estimated $36.3M added.
  • The largest Dr. Reddy's Laboratories seller in Q2 2017 was AQR Capital Management, an estimated $20M sold.

Based on aggregated 13F filings for Q2 2017.